Tus-Pharmaceutical Group Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 186.94 million compared to CNY 153.88 million a year ago. Revenue was CNY 190.05 million compared to CNY 155.33 million a year ago.

Net income was CNY 6.38 million compared to CNY 11.55 million a year ago. Basic earnings per share from continuing operations was CNY 0.0267 compared to CNY 0.0482 a year ago. Diluted earnings per share from continuing operations was CNY 0.0267 compared to CNY 0.0482 a year ago.